2018 Retinal Surgical Device Report: A Global Market Analysis for 2017 to 2023
Our report on the retinal surgical device market is in its 15th edition, and it is the leading industry source for accurate and relevant information on all aspects of the global retinal surgical device market. The report covers currently commercialized devices, as well as device technologies in development, and it provides forecasts for future market activity. Topics include retinal physiology, the epidemiology of retinal disease, patient economics and reimbursements, and retina specialists who provide care. In addition, we include profiles of the companies that participate in the industry.
The 2018 global retinal surgical device market is approaching $2 billion and is expected to grow to $2.5 billion by 2023. Nearly 80 percent of 2018 revenues will come from a wide range of devices used to perform vitrectomy including, vitrectomy machines, procedure packs, and numerous allied products such as ocular gases, silicone oil, scleral buckles, ocular dyes, light sources, dedicated retina instruments, and cryosurgical devices. Since the number of vitrectomy procedures is the key market driver, we look at the underlying disease states that drive the need for vitrectomies and evaluate the current and forecast number of vitrectomies performed by country or region. With the recent approval of the Bausch + Lomb Vitesse hypersonic vitrector, we focus on the potential advantages of this disruptive technology and how it could broaden the indications for vitrectomy.
*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.
Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:
• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists